IM Cannabis (IMCC) Revenue (2020 - 2026)
IM Cannabis' (IMCC) quarterly Revenue came in at $6.3 million in Q1 2026, down 27.35% year-on-year from $8.7 million in Q1 2025, and down 43.73% quarter-over-quarter from $11.2 million in Q4 2025.
IM Cannabis (IMCC) Revenue (2020 - 2026) Analysis & Trends
IM Cannabis' Revenue history runs 7 years deep, the most recent figure standing at $6.3 million for Q1 2026.
- On a quarterly basis, Revenue fell 27.35% year-over-year to $6.3 million in Q1 2026; TTM through Mar 2026 was $36.8 million, a 6.16% decrease from a year earlier, with the FY2025 full-year figure at $39.2 million, down 0.55% from the prior year.
- Revenue declined to $6.3 million in Q1 2026 per IMCC's latest filing, from $11.2 million in the prior quarter.
- Across five years, Revenue topped out at $11.2 million in Q4 2025 and bottomed at $6.3 million in Q1 2026.
- The 5-year median for Revenue is $9.5 million (2024), against an average of $9.5 million.
- Across the five-year window, Revenue soared 70.11% in 2022 and declined 27.35% in 2026, its largest moves.
- Year by year, Revenue stood at $10.7 million in 2022, then declined by 26.24% to $7.9 million in 2023, then increased by 21.48% to $9.5 million in 2024, then grew by 17.82% to $11.2 million in 2025, then tumbled by 43.73% to $6.3 million in 2026.
- Per Business Quant, the three latest IMCC Revenue figures stand at $6.3 million (Q1 2026), $11.2 million (Q4 2025), and $10.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 3.98 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 2.26 Bn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 6.98 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 781.50 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 3.51 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 814.50 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 1.37 Bn |
| 10 | IM Cannabis | 554,496.00 | -177,626.51 | 1.03 Mn | 6.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.33 Mn |
| Dec 31, 2025 | 11.25 Mn |
| Sep 30, 2025 | 10.06 Mn |
| Jun 30, 2025 | 9.16 Mn |
| Mar 31, 2025 | 8.71 Mn |
| Dec 31, 2024 | 9.55 Mn |
| Sep 30, 2024 | 10.18 Mn |
| Jun 30, 2024 | 10.78 Mn |
| Mar 31, 2024 | 8.95 Mn |
| Dec 31, 2023 | 7.86 Mn |
| Sep 30, 2023 | 9.23 Mn |
| Jun 30, 2023 | 9.83 Mn |
| Mar 31, 2023 | 9.27 Mn |
| Dec 31, 2022 | 10.65 Mn |
| Sep 30, 2022 | 10.86 Mn |
| Jun 30, 2022 | 9.96 Mn |
| Mar 31, 2022 | 8.34 Mn |
| Dec 31, 2021 | 7.86 Mn |
| Sep 30, 2021 | 6.39 Mn |
| Jun 30, 2021 | 9.04 Mn |